Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(10)
•••
Post by ttboy29on May 16, 2018 11:40am
65 Views
Post# 28039471

Revenue will be down in Q4? No Way!

Revenue will be down in Q4? No Way!Since I have him on ignore, someone explain to Joker that Q4 ended on March 31st 2018. Those are the revenues that will be reported in June.

If ISOL was worried about their revenues they would have been clearing product in March to make Q4 and their end year look better. Giving offers now won't help their next reported revenues or their year end revenues for 2018.

When he was't shorting he was touting the revenue at $8M for Q4. But now that he is shorting again (Didn' he say only a moron would short under a dollar?) he is suggesting Q4 will be less than Q3.

Having said that I cannot beleive this is at .68. What a Joke....get it?

 I know not funny for any of us Longs.:(
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities